Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 14/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23319128 | 0.86 | PDK2 (0.44) | PDK2HSD11B1NPC1LMNAGAA | |
| SCHEMBL25054783 | 0.86 | PDK2 (0.44) | PDK2HSD11B1NPC1LMNAGAA | |
| SCHEMBL23628245 | 0.85 | HSD11B1 (0.40) | PDK2HSD11B1HTTP2RX7 | |
| SCHEMBL24316333 | 0.82 | SLC6A2 (0.34) | PDK2HSD11B1NPC1LMNAGAA | |
| SCHEMBL25501422 | 0.81 | HSD11B1 (0.37) | PDK2HSD11B1NPSR1P2RX7 | |
| SCHEMBL23609503 | 0.80 | PDK2 (0.51) | PDK2 | |
| SCHEMBL24626708 | 0.79 | PDK2 (0.45) | PDK2HSD11B1NPC1LMNAGAA | |
| SCHEMBL22797173 | 0.79 | PDK2 (0.45) | PDK2HSD11B1NPC1LMNAGAA | |
| SCHEMBL25501503 | 0.79 | PDK2 (0.39) | PDK2HSD11B1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL24316939 | 0.78 | HSD11B1 (0.39) | PDK2HSD11B1NPC1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | EXOC1, EXOC4, CHRM1 | PDK2 2798/4885HSD11B1 3946/4885NPC1 3674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.